Get the Weekly Intelligence Brief — top committee picks every Sunday.
MOH · NYSE · STOCK

Molina Healthcare, Inc.

Healthcare Updated August 11, 2026
$194.63
52W $121.06 – $244.89
51/100
$10.15B
0.75
AI Committee Verdict
Watch
51/100
Conviction: Contested · 33% agreement · 6 analysts
Contested

Is MOH Bullish or Bearish?

Mixed. Innellis AI committee rates Molina Healthcare, Inc. (MOH) Watch with a composite score of 51/100 , based on 6 analysts with 33% agreement. Last updated August 11, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +8.51 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -11.49 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 28.5% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
  • Market regime is bullish (Bull market -- normal position sizing) — Macro
  • News sentiment is positive (+0.25 across 8 articles, 14d) — News
Bear Case
  • ROE of only -0.2% -- cheap may mean cheap for a reason — Value
  • MACD histogram negative -- bearish momentum — Technical
  • Bollinger bandwidth of 28.5% signals elevated volatility — Risk
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of August 11, 2026
Overall Committee Score
51/100
Agreement
33%
Analysts
6
Conviction
Contested
Sector Rank
Top 93%
of 192 Healthcare peers
Value Analyst neutral
42 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
− ROE of only -0.2% -- cheap may mean cheap for a reason
Growth Analyst bearish
40 / 100 · Low confidence
Growth story is weak, decelerating, or inconsistent
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Risk Analyst bearish
35 / 100 · Low confidence
Elevated risk from leverage, volatility, event exposure, or portfolio concentration -- size accordingly
− Bollinger bandwidth of 28.5% signals elevated volatility
Macro Analyst bullish
78 / 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst bullish
66 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.25 across 8 articles, 14d)
Portfolio Manager neutral
55 / 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Open Full Terminal →

Technical Analysis

RSI (14)
38.7
Neutral
MACD Histogram
-1.172
Bearish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$173.01
Resistance
$200.12
Bollinger %B
0.31
Inside Bands
Price vs Moving Averages
EMA 9
$197.03 Below
EMA 21
$203.27 Below
EMA 50
$203.11 Below
EMA 200
$191.13 Above

Fundamental Analysis

Valuation
62
Profitability
31
Financial Health
75
Cash Flow
70
Valuation
P/E Ratio
P/B Ratio 2.39×
PEG Ratio -12.26
Dividend Yield 0.00%
52W High $244.89
52W Low $121.06
Quality & Growth
ROE 1160.0%
ROA 303.3%
Gross Margin 3456.0%
Operating Margin 66.5%
Revenue Growth YoY
Debt / Equity 0.95
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 1215.9 (rich relative to a 15-40x range); Price-to-book of 2.4x; PEG ratio of -12.3 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.6%; Return on assets of 3.0%; Net margin of -0.0%; Gross margin of 34.6%; Current ratio of 1.68 (healthy short-term liquidity); Debt-to-equity of 0.95; Free cash flow per share is positive (5.28); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full MOH Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →

Explore MOH Further

📈 Rating History 💰 Earnings 📰 Recent Events 🔄 What Changed 📖 Thesis Evolution 🔍 Similar Stocks
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime